SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-214130
Filing Date
2013-05-10
Accepted
2013-05-10 16:06:47
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d506909d10q.htm 10-Q 749573
2 EX-31.1 d506909dex311.htm EX-31.1 9432
3 EX-31.2 d506909dex312.htm EX-31.2 9447
4 EX-32.1 d506909dex321.htm EX-32.1 2797
5 EX-32.2 d506909dex322.htm EX-32.2 2700
  Complete submission text file 0001193125-13-214130.txt   5345875

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20130331.xml EX-101.INS 712807
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20130331.xsd EX-101.SCH 47114
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20130331_cal.xml EX-101.CAL 50828
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20130331_def.xml EX-101.DEF 286011
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20130331_lab.xml EX-101.LAB 423365
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20130331_pre.xml EX-101.PRE 329586
Mailing Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139 6172995000
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 13833479
SIC: 2834 Pharmaceutical Preparations